By THE ASSOCIATED PRESS
The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.
Published: February 4, 2015 at 12:00AM
from NYT Business Day http://ift.tt/16j4wkf
from WordPress http://ift.tt/1HWsseE
via Hadi Aboukhater
No comments:
Post a Comment